Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth S Thomson

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Antimicrobial Agents and Chemotherapy|May 26, 2006
In vitro activities of DX-619 and comparison quinolones against gram-positive cocciPaul A Wickman, Jennifer A Black, Ellen Smith Moland, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
In vitro activity of DX-619, a novel des-fluoro(6) quinolone, against a panel of Streptococcus pneumoniae mutants with characterized resistance mechanismsPaul A Wickman, Ellen Smith Moland, Jennifer A Black, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
First occurrence of a Pseudomonas aeruginosa isolate in the United States producing an IMP metallo-beta-lactamase, IMP-18Nancy D Hanson, Ashfaque Hossain, Larry Buck, et al.
Journal of Clinical Microbiology|August 6, 2005
Evaluation of beta-lactamase inhibitors in disk tests for detection of plasmid-mediated AmpC beta-lactamases in well-characterized clinical strains of Klebsiella sppJennifer A Black, Kenneth S Thomson, John D Buynak, et al.
Current Therapeutic Research, Clinical and Experimental|September 27, 2016
A Novel Topical Combination Ointment with Antimicrobial Activity against Methicillin-Resistant Streptococcus aureus, Gram-Negative Superbugs, Yeasts, and Dermatophytic FungiKenneth S Thomson, Gina K Thomson, John Biehle, et al.
International Journal of Antimicrobial Agents|November 13, 2007
Irreproducible piperacillin/tazobactam minimum inhibitory concentrations in microdilution tests with Escherichia coli strainsKenneth S Thomson, Jennifer Black, Ellen Smith Moland, et al.
Journal of Clinical Microbiology|January 1, 2016
Coproduction of KPC-18 and VIM-1 Carbapenemases by Enterobacter cloacae: Implications for Newer β-Lactam-β-Lactamase Inhibitor CombinationsGina K Thomson, James W Snyder, Christi L McElheny, et al.
The Journal of Antimicrobial Chemotherapy|October 26, 2006
In vitro development of resistance to DX-619 and other quinolones in enterococciPaul A Wickman, Jennifer A Black, Ellen Smith Moland, et al.
Antimicrobial Agents and Chemotherapy|December 6, 2006
Klebsiella pneumoniae isolate producing at least eight different beta-lactamases, including AmpC and KPC beta-lactamasesEllen Smith Moland, Seong Geun Hong, Kenneth S Thomson, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 30, 2020
Automated preparation for identification and antimicrobial susceptibility testing: evaluation of a research use only prototype, the BD Kiestra IdentifA/SusceptA systemJames W Snyder, Gina K Thomson, Stacy Heckman, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|May 26, 2006
In vitro activities of DX-619 and comparison quinolones against gram-positive cocciPaul A Wickman, Jennifer A Black, Ellen Smith Moland, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
In vitro activity of DX-619, a novel des-fluoro(6) quinolone, against a panel of Streptococcus pneumoniae mutants with characterized resistance mechanismsPaul A Wickman, Ellen Smith Moland, Jennifer A Black, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
First occurrence of a Pseudomonas aeruginosa isolate in the United States producing an IMP metallo-beta-lactamase, IMP-18Nancy D Hanson, Ashfaque Hossain, Larry Buck, et al.
Journal of Clinical Microbiology|August 6, 2005
Evaluation of beta-lactamase inhibitors in disk tests for detection of plasmid-mediated AmpC beta-lactamases in well-characterized clinical strains of Klebsiella sppJennifer A Black, Kenneth S Thomson, John D Buynak, et al.
Current Therapeutic Research, Clinical and Experimental|September 27, 2016
A Novel Topical Combination Ointment with Antimicrobial Activity against Methicillin-Resistant Streptococcus aureus, Gram-Negative Superbugs, Yeasts, and Dermatophytic FungiKenneth S Thomson, Gina K Thomson, John Biehle, et al.
International Journal of Antimicrobial Agents|November 13, 2007
Irreproducible piperacillin/tazobactam minimum inhibitory concentrations in microdilution tests with Escherichia coli strainsKenneth S Thomson, Jennifer Black, Ellen Smith Moland, et al.
Journal of Clinical Microbiology|January 1, 2016
Coproduction of KPC-18 and VIM-1 Carbapenemases by Enterobacter cloacae: Implications for Newer β-Lactam-β-Lactamase Inhibitor CombinationsGina K Thomson, James W Snyder, Christi L McElheny, et al.
The Journal of Antimicrobial Chemotherapy|October 26, 2006
In vitro development of resistance to DX-619 and other quinolones in enterococciPaul A Wickman, Jennifer A Black, Ellen Smith Moland, et al.
Antimicrobial Agents and Chemotherapy|December 6, 2006
Klebsiella pneumoniae isolate producing at least eight different beta-lactamases, including AmpC and KPC beta-lactamasesEllen Smith Moland, Seong Geun Hong, Kenneth S Thomson, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 30, 2020
Automated preparation for identification and antimicrobial susceptibility testing: evaluation of a research use only prototype, the BD Kiestra IdentifA/SusceptA systemJames W Snyder, Gina K Thomson, Stacy Heckman, et al.
Pageof 5